← Leaderboards

Husseini K Manji

National Institute Of Mental Health

Google Scholar ↗PubMed ↗ORCID ↗

$0

Attributed

$0

Total exposure

0

Grants

0

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding mix

By agency

—

By mechanism

—

Top collaborators

No co-investigators on record.

Most similar at National Institute Of Mental Health

Same institution · by research overlap

Miles A. Herkenham$0

Others in their field

Top investigators on “Lithium”

David B Collum · Cornell University Ithaca$14,340,104
Jeffrey M Testani · Yale University$14,153,479
M. Stanley Whittingham · Suny At Binghamton$11,395,562
Meera Sampath · Suny At Binghamton$9,956,488
Olga Petrova · Suny At Binghamton$9,956,488
Andrew A Nierenberg · Massachusetts General Hospital$9,784,863

Research focus

LithiumDrug Screening /EvaluationMental Disorder ChemotherapyMood DisordersBipolar DisorderValproateBipolar DepressionBehavioral /Social Science Research TagFunctional DisorderChronicAntidepressive AgentsPharmacokineticsWeekNeuronsClinical TrialsDoseResponseGlutamatesPatient Oriented ResearchHuman SubjectPharmaceutical PreparationsMental DepressionRateHuman Therapy Evaluation

Grant awards (87)

Microarray Studies Identify the Anti-Apoptotic, GR Chap. Protein, BAG-1 in BPD$1,120,346

Z01 · FY2008 · MH · contact PI

Glucocorticoid Receptors (GR) in Mitochondria: The Role in Chronic Stress$885,097

Z01 · FY2008 · MH · contact PI

Investigation of Mitochondrial Function in Bipolar Disorder$398,294

Z01 · FY2008 · MH · contact PI

Glutamatergic Modulators for Rapid & Sustained Antidepressant Effect$349,380

Z01 · FY2008 · MH · contact PI

Roles of kainate receptors in behavioral plasticity related to mood disorders$340,064

Z01 · FY2008 · MH · contact PI

Neuronal-Glial Interaction in the Treatment of Bipolar Disorder$281,833

Z01 · FY2008 · MH · contact PI

AMPA receptor trafficking in the pathophysiology and treatment of mood disorders$281,833

Z01 · FY2008 · MH · contact PI

Antidepressant Efficacy & Safety of AMPAkine (Org 24448) in Major Dep Disorder$267,858

Z01 · FY2008 · MH · contact PI

Investigation of NMDA receptor antagonist as antidepressant in animals$246,895

Z01 · FY2008 · MH · contact PI

Testing whether the enzyme GSK-3 is a therapeutically relevant target of lithium$177,019

Z01 · FY2008 · MH · contact PI

Efficacy of the Protein Kinase C Inhibitor Tamoxifen in Treatment of Acute Mania$142,081

Z01 · FY2008 · MH · contact PI

Glucocorticoid Receptors (GR) in Mitochondria: The Role in Chronic Stress$893,609

Z01 · FY2007 · MH · contact PI

Testing whether the enzyme GSK-3 is a therapeutically relevant target of lithium$891,251

Z01 · FY2007 · MH · contact PI

Investigation of Mitochondrial Function in Bipolar Disorder$872,388

Z01 · FY2007 · MH · contact PI

Microarray Studies Identify the Anti-Apoptotic, GR Chap. Protein, BAG-1 in BPD$697,911

Z01 · FY2007 · MH · contact PI

Investigation of NMDA receptor antagonist as antidepressant in animals$580,020

Z01 · FY2007 · MH · contact PI

AMPA Receptor Subunit GluR1 Synaptic Expression and Trafficking$530,506

Z01 · FY2007 · MH · contact PI

Efficacy of the Protein Kinase C Inhibitor Tamoxifen in Treatment of Acute Mania$521,075

Z01 · FY2007 · MH · contact PI

Neuronal-Glial Interaction in the Treatment of Bipolar Disorder$518,717

Z01 · FY2007 · MH · contact PI

A pharmacologic strategy to bring about rapid (next day) antidepressants effects$506,928

Z01 · FY2007 · MH · contact PI

Roles of kainate receptors in behavioral plasticity related to mood disorders$419,690

Z01 · FY2007 · MH · contact PI

Comb Dopamine Agonist & Select Serotonin Reuptake Inhibitor f/Trtmt of Depression$341,882

Z01 · FY2007 · MH · contact PI

Antidepressant Efficacy of an Antiglutamatergic Agent in Bipolar Depression$334,809

Z01 · FY2007 · MH · contact PI

Antidepressant Efficacy & Safety of AMPAkine (Org 24448) in Major Dep Disorder$271,148

Z01 · FY2007 · MH · contact PI

Glutamatergic Modulators for Rapid & Sustained Antidepressant Effect$271,148

Z01 · FY2007 · MH · contact PI

Antiglucocorticoid Therapy in Bipolar Depression with Mifepristone (RU486)$35,367

Z01 · FY2007 · MH · contact PI

Comb Dopamine Agonist & Select Serotonin Reuptake Inhibi$0

Z01 · FY2006 · MH · contact PI

Antidepressant Efficacy & Safety of AMPAkine (Org 24448)$0

Z01 · FY2006 · MH · contact PI

A pharmacologic strategy to bring about rapid (next day)$0

Z01 · FY2006 · MH · contact PI

Testing whether the enzyme GSK-3 is a therapeutically re$0

Z01 · FY2006 · MH · contact PI

Glucocorticoid Receptors (GR) in Mitochondria: The Role$0

Z01 · FY2006 · MH · contact PI

Roles of kainate receptors in behavioral plasticity rela$0

Z01 · FY2006 · MH · contact PI

Investigation of Mitochondrial Function in Bipolar Disor$0

Z01 · FY2006 · MH · contact PI

Microarray Studies Identify the Anti-Apoptotic, GR Chap.$0

Z01 · FY2006 · MH · contact PI

AMPA Receptor Subunit GluR1 Synaptic Expression and Traf$0

Z01 · FY2006 · MH · contact PI

Efficacy of the Protein Kinase C Inhibitor Tamoxifen in$0

Z01 · FY2006 · MH · contact PI

Antidepressant Efficacy of an Antiglutamatergic Agent in$0

Z01 · FY2006 · MH · contact PI

Antiglucocorticoid Therapy in Bipolar Depression with Mi$0

Z01 · FY2006 · MH · contact PI

Neuronal-Glial Interaction in the Treatment of Bipolar D$0

Z01 · FY2006 · MH · contact PI

Investigation of NMDA receptor antagonist as antidepress$0

Z01 · FY2006 · MH · contact PI

Glutamatergic Modulators for Rapid & Sustained Antidepre$0

Z01 · FY2006 · MH · contact PI

Antidepressant Efficacy/Safety of AMPH Akine (Org 24448)$0

Z01 · FY2005 · MH

Antidepressant Efficacy--Dopamine Agonist in BPD$0

Z01 · FY2005 · MH

Soy Isoflavones for the Treatment of Major Depression$0

Z01 · FY2005 · MH

Antiglucocorticoid Therapy in Bipolar Depression--RU486$0

Z01 · FY2005 · MH

Antidepressant Efficacy of Memantine in Major Depression$0

Z01 · FY2005 · MH

Felbamate for Treatment-Resistant Bipolar Depression$0

Z01 · FY2005 · MH

Efficacy of Clozapine for Treatment-Resistant Mania$0

Z01 · FY2005 · MH

Antidepressant/Antiglutamatergic in Bipolar Depression$0

Z01 · FY2005 · MH

Antidepressant/Antiglutamatergic Agent-Major Depression$0

Z01 · FY2005 · MH

Protein Kinase C Inhibitor Tamoxifen-Acute Mania$0

Z01 · FY2005 · MH

AMPA Receptor GluR1 Synaptic Expression/Trafficking$0

Z01 · FY2005 · MH

Microarray Studies-Anti-Apoptotic, GR Chap. Protein BAG$0

Z01 · FY2005 · MH

Investigation Mitochondrial Function in Bipolar Disorder$0

Z01 · FY2005 · MH

Neuronal-Glial Interaction-Treatment of Bipolar Disorder$0

Z01 · FY2005 · MH

Glucocorticoid Receptors in Mitochondria: Chronic Stress$0

Z01 · FY2005 · MH

Testing whether enzyme GSK-3 therapeutic target/lithium$0

Z01 · FY2005 · MH

ERK pathway--modulation animal behavior--mood disorders$0

Z01 · FY2005 · MH

A pharmacologic strategy--rapid antidepressant effects$0

Z01 · FY2005 · MH

Dopamine Agonist/Select Serotonin Reuptake Inhibibitor$0

Z01 · FY2005 · MH

Glutamatergic Modulators--Rapid Sustained Antidepressant$0

Z01 · FY2005 · MH

Antidepressant Efficacy of Dopamine Agonist w/ Neurotrop$0

Z01 · FY2004 · MH

ERK and treatment of severe mood disorders: biochemical$0

Z01 · FY2004 · MH

Testing whether the enzyme GSK-3 is a therapeutically re$0

Z01 · FY2004 · MH

Glucocorticoid Receptors (GR) in Mitochondria: The Role$0

Z01 · FY2004 · MH

Neuronal-Glial Interaction in the Treatment of Bipolar D$0

Z01 · FY2004 · MH

Investigation of Mitochondrial Function in Bipolar Disor$0

Z01 · FY2004 · MH

Microarray Studies of Anti-Apoptotic, BAG-1 in BPD$0

Z01 · FY2004 · MH

AMPA Receptor Subunit GluR1 Synaptic Expression and Traf$0

Z01 · FY2004 · MH

The Protein Kinase C Inhibitor Tamoxifen in Acute Mania$0

Z01 · FY2004 · MH

Antidepressant Efficacy of Antiglutamatergic w/Neurotrop$0

Z01 · FY2004 · MH

Antidepressant Efficacy of Antiglutamatergic in BPD$0

Z01 · FY2004 · MH

Efficacy of Clozapine for Treatment-Resistant Mania$0

Z01 · FY2004 · MH

Felbamate for Treatment-Resistant Bipolar Depression$0

Z01 · FY2004 · MH

Efficacy of Memantine for Major Depression$0

Z01 · FY2004 · MH

Antiglucocorticoid Therapy in Bipolar Depression with Mi$0

Z01 · FY2004 · MH

Soy Isoflavones for the Treatment of Major Depression$0

Z01 · FY2004 · MH

Microarray Studies -- Long Term Treatment for Bipolar$0

Z01 · FY2003 · MH

Neuronal-Glial Interaction in the Treatment of Bipolar$0

Z01 · FY2003 · MH

GSK-3 Signaling: Targeting Actions of Mood Stablizing$0

Z01 · FY2003 · MH

Investigation of Mitochondrial Function in Bipolar$0

Z01 · FY2003 · MH

Microarray Studies Identify Components in Bipolar$0

Z01 · FY2003 · MH

AMPA Receptor Subunit GluR1 Synaptic Expression/Traffick$0

Z01 · FY2003 · MH

Efficacy of the Protein Kinase C Inhibitor Tamoxifen$0

Z01 · FY2003 · MH

Antidepressant Efficacy of Antiglutamatergic Agent$0

Z01 · FY2003 · MH

Investigation of Antidepressant Efficacy in BPD$0

Z01 · FY2003 · MH

Antidepressant Efficacy of Dopamine Agonist in BPD$0

Z01 · FY2003 · MH